Cannabotech is a next-generation CBD botanical pharmacy company, that brings to the market a unique and powerful range of preventative care CBD products, expertly created with today’s fast-paced, modern life in mind.
Our goal is to help our customers proactively and continuously supercharge their health and wellbeing. We do it by offering a wide range of innovative, scientifically based preventative-health solutions.
Our products are based on the unique M2CBD formula creating a supercharged, integrative effect on your health. The powerful combination of pharmaceutical-grade, isolated CBD and a unique blend of functional mushrooms simultaneously targets both your immune and your endocannabinoid systems, creating a supercharged effect on your health.
Also as part of our philosophy, we believe in a personalization treatment with an option of a 1:1 meeting with our professional healthcare & a DNA kit in our MyBeing program subscription (6 or 4 months).
How did you come up with the idea for the company?
In 2016 I discovered the scientific virtues of functional mushrooms during my stay in the Far East. I assembled a well-experienced and professional team from the pharmaceutical industry to create an advanced business model, with Prof. Fuad Fares & Prof Solomon Wasser, world leaders in mushroom research.
In 2018 the team realised the options of combining the mushrooms with the hemp plant and signed a partnership with Haifa University, Israel to accelerate the process to find integrative and preventative solutions focusing on these two elements.
More from Interviews
- A Chat With Paul Beare, Founder Of Paul Beare Ltd On UK Companies Going International
- Get To Know Taiwo Akinropo, Founder And CEO At Heyfood And MENA40 Judge
- A Chat With Obinna Umeh, Co-Founder And CEO of Growwr And MENA40 2026 Judge
- We Spoke To Furkat Kasimov, Tech Entrepreneur, Venture Studio Founder And MENA40 2026 Judge About The Future Of Tech In The Middle East And North Africa
- Interview With Andrew Henderson, Chief Technology Officer At OneAdvanced On Embedding AI Into Workflows
- A Conversation With Nakul Kothari, Head of APAC And Middle East At Juspay On Payment Orchestration
- A Chat With Igor Kulatov, Co-Founder And CTO Of Aurora Borealis: Five Years Running Autonomous B2B Commerce In Production
- Interview with Ebenezer Ojo, Co-Founder At Taxmingo And MENA40 Judge
How has the company evolved during the pandemic?
The team were in the early stages of research and creating the business infrastructure when the pandemic hit. Working from home made us more efficient in our processes – in fact, our second fundraising round, which raised over 3M€ (From a total of 10M€) was completed during the pandemic. It has only been in the last few months that we have gone back to working from the offices and in August we visited the UK and closed all our contracts & partnerships.
What can we hope to see from Cannabotech in the future?
We have just opened our first store in Westfield, White City, London, and we are aiming for three more stores in the next year. The UK is the biggest and fastest growing CBD market in Europe, which is only second to the U.S market.
In Q2 of 2022 we will be expanding our franchise into Europe and the US, whilst also launching our integrative solution (5 types of Cancer) into Israel and the U.S.
